Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · IEX Real-Time Price · USD
6.56
-0.50 (-7.08%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $192.84 million as of April 25, 2024. Its market cap has decreased by -19.41% in one year.
Market Cap
192.84M
Enterprise Value
125.33M
1-Year Change
-19.41%
Ranking
Category
Stock Price
$6.56
Market Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $192.84M, an increase of 1,054.73%. That is a compound annual growth rate of 24.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 193.50M | 1.42% |
Apr 23, 2024 | 190.80M | -2.95% |
Apr 22, 2024 | 196.60M | 4.69% |
Apr 19, 2024 | 187.80M | 2.74% |
Apr 18, 2024 | 182.80M | -8.00% |
Apr 17, 2024 | 198.70M | -6.36% |
Apr 16, 2024 | 212.20M | -8.30% |
Apr 15, 2024 | 231.40M | -6.20% |
Apr 12, 2024 | 246.70M | -1.00% |
Apr 11, 2024 | 249.20M | 1.14% |
Apr 10, 2024 | 246.40M | 0.08% |
Apr 9, 2024 | 246.20M | -1.64% |
Apr 8, 2024 | 250.30M | -4.28% |
Apr 5, 2024 | 261.50M | 4.47% |
Apr 4, 2024 | 250.30M | 3.30% |
Apr 3, 2024 | 242.30M | 2.76% |
Apr 2, 2024 | 235.80M | 0.47% |
Apr 1, 2024 | 234.70M | 9.37% |
Mar 28, 2024 | 214.60M | -1.42% |
Mar 27, 2024 | 217.70M | -2.20% |
Mar 26, 2024 | 222.60M | -6.35% |
Mar 25, 2024 | 237.70M | -5.75% |
Mar 22, 2024 | 252.20M | 1.00% |
Mar 21, 2024 | 249.70M | 5.89% |
Mar 20, 2024 | 235.80M | 4.75% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elevation Oncology | 210.17M |
Galectin Therapeutics | 209.23M |
Poseida Therapeutics | 208.42M |
X4 Pharmaceuticals | 206.56M |
Design Therapeutics | 204.97M |
Codexis | 203.88M |
Century Therapeutics | 203.21M |
Rigel Pharmaceuticals | 199.93M |